16-1510952-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014714.4(IFT140):c.4381G>A(p.Asp1461Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000176 in 1,611,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D1461D) has been classified as Likely benign.
Frequency
Consequence
NM_014714.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IFT140 | NM_014714.4 | c.4381G>A | p.Asp1461Asn | missense_variant | 31/31 | ENST00000426508.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IFT140 | ENST00000426508.7 | c.4381G>A | p.Asp1461Asn | missense_variant | 31/31 | 5 | NM_014714.4 | P1 | |
IFT140 | ENST00000361339.9 | c.1963G>A | p.Asp655Asn | missense_variant | 13/13 | 1 | |||
IFT140 | ENST00000565298.5 | n.4205G>A | non_coding_transcript_exon_variant | 19/19 | 2 | ||||
IFT140 | ENST00000397417.6 | c.*2819G>A | 3_prime_UTR_variant, NMD_transcript_variant | 24/24 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152256Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000167 AC: 41AN: 245808Hom.: 0 AF XY: 0.000187 AC XY: 25AN XY: 133364
GnomAD4 exome AF: 0.000175 AC: 256AN: 1458938Hom.: 0 Cov.: 32 AF XY: 0.000207 AC XY: 150AN XY: 725576
GnomAD4 genome AF: 0.000177 AC: 27AN: 152374Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74506
ClinVar
Submissions by phenotype
Saldino-Mainzer syndrome Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2022 | The c.4381G>A (p.D1461N) alteration is located in exon 31 (coding exon 29) of the IFT140 gene. This alteration results from a G to A substitution at nucleotide position 4381, causing the aspartic acid (D) at amino acid position 1461 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Saldino-Mainzer syndrome;C4540439:Retinitis pigmentosa 80 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 09, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at